Induction of immune tolerance: A role for natural killer T lymphocytes?

Liver International

Volumn 25, Issue 3, 2005, Pages 501-504

  Margalit, Maya ^a   Ilan, Yaron ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Anterior chamber associated immune deviation; NKT lymphocytes; Oral tolerance; Tolerance; Transplantation

Indexed keywords

CD28 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OKT 4;

ADOPTIVE TRANSFER; CELL ACTIVITY; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PREDICTION; PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; T-LYMPHOCYTES;

EID: 20844433412     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01147.x     Document Type: Review

References (32)

1. Emoto M, Kaufmann S H E. Liver NKT cells: an account of heterogeneity. Trends Immunol 2003; 24: 364-9.
2. Crispe I N. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003; 3: 51-62.
3. Chen H, Paul W E. Cultured NK1.1+CD4+T cells produce large amounts of IL-4 and IFNγ upon activation by anti-CD3 or CD1. J Immunol 1997; 159: 2240.
4. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997; 278: 1626-9.
5. Smyth M J, Crowe N Y, Hayakawa Y, Takeda K, Yagita H, Godfrey D. NKT cells-conductors of tumor immunity? Curr Opin Immunol 2002; 14: 165-71.
6. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, Nakayama T, Taniguchi M. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000; 191: 105-14.
7. Lee P T, Putnam A, Benlagha K, Teyton L, Gottlieb P A, Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 2002; 110: 747-8.
8. Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson D D, Carbone D P, Paul W E, Berzofsky J A. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000; 1: 515-20.
9. Moodycliffe A M, Nghiem D, Clydesdale G, Ullrich S E. Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000; 1: 521-5.
10. Ikehara Y, Yasunami Y, Kodama S, Maki T, Nakano M, Nakayama T, Taniguchi M, Ikeda S. CD4+Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest 2000; 105: 1761-7.
11. Seino K, Fukao K, Muramoto K, Yanagisawa K, Takada Y, Kakuta S, Iwakura Y, Van Kaer L, Takeda K, Nakayama T, Taniguchi M, Bashuda H, Yagita H, Okumura K. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci 2001; 98: 2577-81.
12. Stein-Streilein J, Sonoda K, Faunce D, Zhang-Hoover. Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages. J Leukoc Biol 2000; 67: 488-94.
13. Sonoda K, Stein-Streilein J. Ocular immune privilege and CD1d-reactive natural killer T cells. Cornea 2002; 21: S33-8.
14. Sonoda K, Exley M, Snapper S, Balk S P, Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 1999; 190: 1215-25.
15. Faunce D E, Sonoda K, Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 2001; 166: 313-21.
16. Faunce D E, Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002; 169: 31-8.
17. Nakamura T, Sonoda K, Faunce D E, Gumperz J, Yamamura T, Miyake S, Stein-Streilein J. CD4+NKT cells, but not conventional CD4+T cells, are required to generate efferent CD8+T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol 2003; 171: 1266-71.
18. Sonoda K, Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol 2002; 32: 848-57.
19. Wang Y, Goldschneider I, O'Rourke J, Cone R. Blood mononuclear cells induce regulatory NKT thymocytes in anterior chamber-associated immune deviation. J Leukoc Biol 2001; 69: 741-46.
20. Weiner H L. Oral tolerance: immune mechanisms and generation of Th3-type TGFβ secreting regulatory cells. Microbes Infect 2001; 3: 947-54.
21. Callery M P, Kamei T, Flye M W. Kupffer cell blockade inhibits induction of tolerance by the portal venous route. Transplantation 1989; 47: 1092-4.
22. Yu S Y, Nakafusa Y, Flye M W, Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery 1994; 116: 229-34.
23. Neurath N, Kelasall B L, Presky D H, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med 1996; 183: 2605-16.
24. Trop S, Samsonov D, Gotsman I, Alper R, Diment J, Ilan Y. Liver-associated lymphocytes expressing NKL1.1 are essential for oral immune tolerance induction in a murine model. Hepatology 1999; 29: 746-55.
25. Shibolet O, Kalish Y, Klein A, Alper R, Zolotarov L, Thalenfeld B. Engelhardt D, Rabbani E, Ilan Y. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis. J Leukoc Biol 2004; 75: 76-86.
26. Trop S, Ilan Y. NK1.1+T cell: a two-faced lymphocyte in immune modulation of the IL-4/IFNγ paradigm. J Clin Immunol 2002; 22: 270-9.
27. Samsonov D, Trop S, Alper R, Diment J, Ilan Y. Enhancement of immune tolerance via induction of NK1.1 positive liver-associated-lymphocytes under immunosuppressive conditions. J Hepatol 2000; 32: 812-20.
28. Shlomai A, Trop S, Gotsman I, Jurim O, Diment J, Alper R, Rabbani E, Engelhardt D, Ilan Y. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens - bystander effect. J Pathol 2001; 195: 498-507.
29. Ishimitsu R, Yajima T, Nishimura H, Kawauchi H, Yoshikai Y. NKT cells are dispensable in the induction of oral tolerance but are indispensable in the abrogation of oral tolerance by prostaglandin E. Eur J Immunol 2003; 33: 183-93.
30. Melero I, Johnston J V, Shufford W, Mittler R S, Chen L. NK1.1 cell express 4-1BB constimulatory molecule and are required for tumor immunity elicted by anti41BB monoclonal antibodies. Cell Immunol 1998; 190: 167-72.
31. Ilan Y, Roy Chowdhury N, Sauter B S, Thummala N R, Davidson A, Horwitz M S, Nakamura J, Fox I J, Roy Chowdhury J. A critical role of the liver in inducing oral tolerance to adenoviral vectors for long-term gene therapy. Gastroenterology 1998; 114: 260A.
32. Crispe N, Mehal W Z. Strange brew: T cells in the liver. Immunol Today 1996; 11: 236-45.